Healthtexas Provider Network
Healthtexas Provider Network was paid $1.31M by Medicaid between Jan 2018 and Dec 2024, across 61 billing codes. Its largest line is 99392, Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) — 21% of everything it billed.
PLANO, TX 75093
Next to other Physical Medicine & Rehabilitation Physician providers in Texas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,984 | $4K | |
| 2019 | 2,616 | $11K | |
| 2020 | 4,320 | $50K | |
| 2021 | 21,243 | $324K | |
| 2022 | 21,123 | $320K | |
| 2023 | 17,376 | $334K | |
| 2024incomplete | 12,918 | $266K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 21% | 3,920 | 3,550 | $280K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 15% | 2,956 | 2,684 | $203K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 13% | 2,083 | 1,999 | $166K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 11% | 17,660 | 6,546 | $140K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 9.0% | 1,385 | 1,316 | $118K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.2% | 1,914 | 1,810 | $81K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.7% | 4,716 | 2,232 | $62K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.1% | 4,250 | 3,795 | $53K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.4% | 1,126 | 1,104 | $32K |
| 87428 | 1.8% | 440 | 420 | $24K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.7% | 7,704 | 6,393 | $23K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.5% | 2,630 | 2,071 | $19K |
49 more codes
| 99381 | 1.3% | 249 | $17K | |
| 92551 | 1.0% | 1,673 | $14K | |
| 87430 | <1% | 809 | $11K | |
| 90461 | <1% | 1,671 | $10K | |
| 87807 | <1% | 1,035 | $10K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 739 | $9K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 90 | $7K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 187 | $7K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 520 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,803 | $4K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 323 | $3K |
| 99174 | <1% | 814 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 40 | $2K |
| 87400 | <1% | 115 | $1K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 129 | $1K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 55 | $963.44 |
| 99383 | <1% | 13 | $839.82 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 40 | $763.75 |
| 99307 | <1% | 379 | $430.48 | |
| 87420 | <1% | 33 | $350.40 | |
| 81003 | <1% | 133 | $267.56 | |
| 90686 | <1% | 2,306 | $157.76 | |
| 0002A | <1% | 18 | $38.00 | |
| 99173 | <1% | 846 | $8.75 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,101 | $7.25 |
| 90734 | <1% | 275 | $0.91 | |
| 90620 | <1% | 66 | $0.47 | |
| 90715 | <1% | 66 | $0.29 | |
| 90651 | <1% | 240 | $0.25 | |
| 90716 | <1% | 380 | $0.02 | |
| 90633 | <1% | 1,265 | $0.02 | |
| 90707 | <1% | 370 | $0.02 | |
| 90677 | 0% | 607 | $0.00 | |
| 90723 | 0% | 1,904 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 1,212 | $0.00 |
| 90696 | 0% | 156 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 695 | $0.00 |
| 90680 | 0% | 1,762 | $0.00 | |
| 1111F | 0% | 505 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 623 | $0.00 |
| 90656 | 0% | 222 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 13 | $0.00 |
| 90381 | 0% | 12 | $0.00 | |
| 80061 | Lipid panel | 0% | 975 | $0.00 |
| 90670 | 0% | 2,011 | $0.00 | |
| 90648 | 0% | 2,590 | $0.00 | |
| 90710 | 0% | 184 | $0.00 | |
| 90700 | 0% | 379 | $0.00 | |
| 3725F | 0% | 163 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Healthtexas Provider Network | Dallas, TX | $3.72M |
| Angels Harbor | Belpre, OH | $2.28M |
| Healthtexas Provider Network | Colleyville, TX | $32K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.